USPTO serial 79300858
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations in the form of luminous particles containing quantum dots for industrial purposes; in vitro diagnostic reagents containing quantum dots for scientific purposes; chemical preparations in the form of semiconductor nanocrystal particles containing quantum dots for fluorescent biolabeling; chemical preparations for fluorescence emission containing quantum dot nanoparticles with semiconductor properties | ACTIVE | — |
| 005 | In vitro diagnostic preparations containing quantum dots for medical purposes; diagnostic reagents containing quantum dots for medical purposes | ACTIVE | — |
| 009 | Biosensors for sensing radiation, light, electricity, gases, liquids, solids or air; diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for the detection of proteins, antigens, and antibodies for laboratory and research use; sensors for measuring light intensity and chemical identity, other than for medical use; downloadable and recorded computer software for diagnosing diseases for medical purposes; electrochemical gas sensors | ACTIVE | — |
| 010 | Medical diagnostic apparatus equipped with quantum dots for diagnosing heart and inflammatory disease, cancer, and infectious disease; Measuring instruments for medical purposes equipped with quantum dots, namely, medical instruments for measuring a level of specific protein, antigen, and antibody in a sample; test equipment for medical use equipped with quantum dots, namely, blood testing apparatus, medical diagnostic apparatus for testing a level of specific protein, antigen, and antibody in a sample; blood analysis apparatus for diagnosis equipped with quantum dots; body fluid analysis apparatus equipped with quantum dots, namely, medical diagnostic instruments for the analysis of body fluids; in vitro diagnostic devices for medical purposes equipped with quantum dots, namely, diagnostic apparatus for diagnosing heart and inflammatory disease, cancer, and infectious disease; blood testing apparatus equipped with quantum dots; blood analysis equipment equipped with quantum dots; apparatus for blood analysis equipped with quantum dots | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 26, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 13, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 12, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 3, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 13, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 20, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 19, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 23, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 12, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 25, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 25, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 17, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 24, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 24, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 17, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 17, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 17, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 4, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 4, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 20, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 20, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 21, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 21, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 20, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 19, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 1, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |